Skip to main content
Elsevier
View Cart

Books in Pharmaceutical science general

BooksJournals

    • Light, Molecules, Reaction and Health

      • 1st Edition
      • November 30, 2019
      • Angelo Albini
      • English
      • Paperback
        9 7 8 0 1 2 8 1 1 6 5 9 3
      • eBook
        9 7 8 0 1 2 8 1 1 8 5 5 9
      Light, Molecules, Reaction and Health offers a comprehensive overview of health-related, light-based processes and systems, paying special attention to molecular photochemistry. Users of photochemical methods and concepts in pharmacology and biomedicine will find detailed information on the basic processes underlying the biological effects of natural and artificial light—from the primary absorption event occurring in an endogenous or exogenous molecule in a biological compartment, to the final pathological or beneficial outcome. By emphasizing novel methods, including nanostructured materials in therapy and diagnostics, this book allows readers to critically interpret existing data with a goal of stimulating new research in phytotherapy and phytomedicine.

    • Principles of Parenteral Solution Validation

      • 1st Edition
      • November 27, 2019
      • Igor Gorsky + 1 more
      • English
      • Paperback
        9 7 8 0 1 2 8 0 9 4 1 2 9
      • eBook
        9 7 8 0 1 2 8 0 9 4 4 6 4
      Principles of Parenteral Solution Validation: A Practical Lifecycle Approach covers all aspects involved in the development and process validation of a parenteral product. By using a lifecycle approach, this book discusses the latest technology, compliance developments, and regulatory considerations and trends, from process design, to divesting. As part of the Expertise in Pharmaceutical Process Technology series edited by Michael Levin, this book incorporates numerous case studies and real-world examples that address timely problems and offer solutions to the daily challenges facing practitioners in this area.

    • Polymeric Nanoparticles as a Promising Tool for Anti-cancer Therapeutics

      • 1st Edition
      • June 25, 2019
      • Prashant Kesharwani + 2 more
      • English
      • Paperback
        9 7 8 0 1 2 8 1 6 9 6 3 6
      • eBook
        9 7 8 0 1 2 8 1 7 3 3 1 2
      Polymeric Nanoparticles as Promising Tool for Anti-cancer Therapeutics provides an understanding of polymeric compounds and their use in cancer therapies. The book begins by giving an overview of the current status, future challenges and potential utilization of polymeric nanoparticles. It then covers specific polymeric nanoparticles through contributions from world-renowned experts and researchers. Chapters examine specific polymeric nanoparticles, their development as potential targeted delivery systems, and cancer characteristics that can be targeted for therapy development. The book synthesizes current research trends in the field, thus enhancing existing knowledge of nanomedicine, drug delivery and therapeutic intervention strategies in human cancers. Users will find this to be an ideal reference for research scientists and those in the pharmaceutical and medical fields who are working to develop novel cancer therapies using nanoparticle-based delivery systems.

    • Equipment Qualification in the Pharmaceutical Industry

      • 1st Edition
      • June 13, 2019
      • Steven Ostrove
      • English
      • Paperback
        9 7 8 0 1 2 8 1 7 5 6 8 2
      • eBook
        9 7 8 0 1 2 8 1 7 5 6 9 9
      Equipment Qualification in the Pharmaceutical Industry provides guidance and basic information for the preparation of a quality qualification program. It has been noted that there is a general lack of understanding in the industry, especially for those new to the industry, as to what constitutes a compliant qualification program. Even experienced professionals have felt a lack of security in reaching a compliant state. This book outlines a guideline for the preparation and execution of qualification protocols including the installation (IQ), operational (OQ), and performance (PQ) protocols. It discusses the importance of related qualification programs (e.g., quality systems, commissioning, computer system, and cleaning) and how to incorporate them into a fully compliant qualification program. Furthermore, it provides matrices of what could be included in each type of protocol for major types of process equipment. While primarily for people entering the pharmaceutical industry, those established in the field will benefit from the multiple examples and matrices as well as integration of related systems. Equipment Qualification in the Pharmaceutical Industry provides students and pharmaceutical scientists a guideline for the preparation and execution of qualification (installation, operational, and performance) protocols.

    • Biomarkers, Diagnostics and Precision Medicine in the Drug Industry

      • 1st Edition
      • June 8, 2019
      • Abdel Halim
      • English
      • Paperback
        9 7 8 0 1 2 8 1 6 1 2 1 0
      • eBook
        9 7 8 0 1 2 8 1 6 1 2 2 7
      The high failure rate in the pharmaceutical industry has positioned biomarkers and personalized medicine in the frontline, as possible solutions. If executed right, biomarkers and companion diagnostics (CDx) can potentially help the drug industry enhance the probability of success, accelerate the time to market, and, more importantly, benefit patients by supporting accurate diagnosis and selection of the most effective and least toxic therapies. This book aims to examine the challenges and limitations in biomarkers and laboratory tests. It also offers advice on best practices to ensure proper application of biomarkers and bridges the gap between diagnostic business development claims and real-life deliverables. The book covers biomarkers for different purposes, provides examples from different technologies, which includes standard-of-care approved assays as well as for-investigational-... and for-research-use-onl... assays. It also includes new data for biomarkers in different therapeutic indications and offers case studies and practical examples. This book serves as a reference to drug developers, IVD providers, clinical labs, healthcare givers, academicians, and researchers for best practices to help increase the probability of success in drug development and improve patient management.

    • The Core Model

      • 1st Edition
      • June 4, 2019
      • Ibis Sanchez Serrano
      • English
      • Paperback
        9 7 8 0 1 2 8 1 4 2 9 3 6
      • eBook
        9 7 8 0 1 2 8 1 4 2 9 4 3
      The Core Model: A Collaborative Paradigm for the Pharmaceutical Industry and Global Health Care develops the innovative core model, an organizational research and design paradigm and economic theory that proposes a collaborative approach to resolving global health issues and improving the productivity of drug development. The model proposes that scientific collaboration does not occur in an unstructured manner, but actually takes place within a highly structured order where knowledge is transferred, integrated and finally translated into commercial products. An understanding of this model will help solve the global pharmaceutical industry´s productivity problems and address important global health care and economic issues. This book is useful to researchers, advanced students, regulators, and management in pharmaceutical industries, as well as healthcare professionals, those working in health economics, and those interested in scientific innovation processes.

    • NETosis

      • 1st Edition
      • June 1, 2019
      • Geeta Rai
      • English
      • Paperback
        9 7 8 0 1 2 8 1 6 1 4 7 0
      • eBook
        9 7 8 0 1 2 8 1 6 3 7 9 5
      NETosis: Immunity, Pathogenesis and Therapeutics takes a focused approach to the clinical aspects of NETosis and drug development, bringing critical findings. Chapters introduce NETosis, consider mechanisms and antimicrobial strategies regulating NETosis, examine NETosis in neonates, explore the role of NETosis in autoimmunity, delve into NETosis and other diseases, and present therapeutic approaches for dysregulated NETosis. Since Brinkamm, et al, discovered an unrecognized neutrophil anti-microbial mechanism responsible for the extracellular killing of invading pathogens in 2004, the novel process in which nuclear chromatin de-condenses and DNA is ejected into the extra cellular environment, trapping and inactivating tissue pathogens has rapidly evolved.

    • Biomaterials and Bionanotechnology

      • 1st Edition
      • May 29, 2019
      • English
      • Hardback
        9 7 8 0 1 2 8 1 4 4 2 7 5
      • eBook
        9 7 8 0 1 2 8 1 4 4 2 8 2
      Biomaterials and Bionanotechnology examines the current state of the field within pharmaceutical sciences and concisely explains the history of biomaterials including key developments. Written by experts in the field, this volume within the Advances in Pharmaceutical Product Development and Research series deepens understanding of biomaterials and bionanotechnology within drug discovery and drug development. Each chapter delves into a particular aspect of this fast-moving field to cover the fundamental principles, advanced methodologies and technologies employed by pharmaceutical scientists, researchers and pharmaceutical industries to transform a drug candidate or new chemical entity into a final administrable dosage form, with particular focus on biomaterials and bionanomaterials. This book provides a comprehensive examination suitable for researchers working in the pharmaceutical, cosmetics, biotechnology, food and related industries as well as advanced students in these fields.

    • New Developments in Nanosensors for Pharmaceutical Analysis

      • 1st Edition
      • May 22, 2019
      • Sibel A. Ozkan + 1 more
      • English
      • Paperback
        9 7 8 0 1 2 8 1 6 1 4 4 9
      • eBook
        9 7 8 0 1 2 8 1 6 3 7 8 8
      New Developments for Nanosensors in Pharmaceutical Analysis presents an overview of developments in nanosensor usage in pharmaceutical analysis, thereby helping pharmaceutical companies attain reliable, precise, and accurate analysis of pharmaceuticals. This book presents very simple, precise, sensitive, selective, fast, and relatively inexpensive methods for pre-treatment, prior to analysis. These methods may be considered for further application in clinical studies and assays. The book includes the manufacturing of sensors for pharmaceutical analysis at nano- or smaller scales, and gives simple and relatable designs for the fabrication of sensors. Twelve chapters cover an introduction to the topic, immobilization techniques, mechanism effect of nanomaterials on structure, optical nanosensors for pharmaceutical detection, chemical nanosensors in pharmaceutical analysis, noble metal nanoparticles in electrochemical analysis of drugs, photo-electrochemica... nanosensors for drug analysis, molecularly imprinted polymer based nanosensors for pharmaceutical analysis, nanomaterials for drug delivery systems, nanomaterials enriched nucleic acid-based biosensors, nanosensors in biomarker detection, and nanomaterials-based enzyme biosensors for electrochemical applications.

    • Companion and Complementary Diagnostics

      • 1st Edition
      • May 8, 2019
      • Jan Trøst Jørgensen
      • English
      • Paperback
        9 7 8 0 1 2 8 1 3 5 3 9 6
      • eBook
        9 7 8 0 1 2 8 1 3 5 4 0 2
      Companion and Complementary Diagnostics: From Biomarker Discovery to Clinical Implementation provides readers with in-depth insights into the individual steps in the development of companion diagnostic assays, from the early biomarker discovery phase straight through to final regulatory approval. Further, the clinical implementation of companion diagnostic testing in the clinic is also discussed. As the development of predictive or selective biomarker assays linked to specific drugs is substantially increasing, this book offers comprehensive information on this quickly-evolving area of biomedicine. It is an essential resource for those in academic institutions, hospitals and pharma, and biotech and diagnostic commercial companies.

Related subjects

Pharmaceutical science